# A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas

> **NCT01985958** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 4 (actual)

## Conditions studied

- Histological or Cytological Diagnosis of Pancreatic Carcinoma

## Interventions

- **DEVICE:** Radiation therapy

## Key facts

- **NCT ID:** NCT01985958
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-09
- **Final completion:** 2019-12
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01985958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01985958, "A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01985958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*